Showing 55–63 of 65 results
-
AED3,500.00
The PD-L1 (22C3) Dako CPS (IHC) test is an immunohistochemistry (IHC) assay designed to assess PD-L1 expression in tumor and immune cells using the Combined Positive Score (CPS). It is FDA-approved as a companion diagnostic for multiple cancer therapies, ensuring precise patient selection for immune checkpoint inhibitors. The test utilizes the 22C3 monoclonal antibody, providing high sensitivity and specificity in detecting PD-L1 expression. Its standardized scoring system (CPS) enhances reproducibility and clinical decision-making, making it a trusted tool for oncologists. The Dako platform ensures consistent, high-quality staining, supporting accurate and reliable results for personalized cancer treatment.
-
-
AED3,200.00
PredictLife Test is a cutting-edge DNA-based health and longevity assessment that provides personalized insights into your genetic predispositions, lifestyle risks, and potential health outcomes. Using advanced AI and genomic analysis, it evaluates factors like disease risks, aging patterns, nutrition, and fitness optimization.
-
AED2,400.00
The Prothrombin Mutation Analysis is a genetic test designed to detect the G20210A mutation in the prothrombin (F2) gene, a key risk factor for inherited thrombophilia. This highly accurate, DNA-based assay identifies individuals with increased risk of abnormal blood clotting, aiding in the diagnosis and management of thrombotic disorders.
-
AED3,750.00
The **Ros1 – Fish Test** is a highly sensitive and reliable fluorescence in situ hybridization (FISH) assay designed for the detection of **ROS1 gene rearrangements** in tumor samples. This test is crucial for identifying patients who may benefit from targeted therapies, particularly in **non-small cell lung cancer (NSCLC)**. Key features include **high specificity and accuracy**, rapid turnaround time, and **direct visualization of gene rearrangements** at the cellular level. Its benefits include **early and precise diagnosis**, enabling personalized treatment decisions and improving patient outcomes. The **unique selling point** of the Ros1 – Fish Test is its **proven clinical utility in guiding targeted therapy selection**, making it an essential tool for oncologists and pathologists in precision medicine.
-
-
-
-
AED2,000.00
The **SPINAL MUSCULAR ATROPHY (SMA) Test** is a cutting-edge genetic screening tool designed to detect mutations in the **SMN1 gene**, the primary cause of SMA, a severe neuromuscular disorder. This highly accurate test enables **early diagnosis**, allowing for timely medical intervention and personalized treatment plans. It is **non-invasive**, requiring only a simple blood or saliva sample, and delivers **fast, reliable results**. Ideal for **newborn screening, carrier detection, and prenatal testing**, it empowers individuals and families with crucial genetic insights. With advanced technology ensuring **high sensitivity and specificity**, this test is a must-have for proactive healthcare and informed decision-making.
